Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?
Bayer Aktiengesellschaft is one of 1011 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Bayer Aktiengesellschaft is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for BAYRY's full-year earnings has moved 5.3% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, BAYRY has gained about 33.4% so far this year. In comparison, Medical companies have returned an average of 4.4%. This means that Bayer Aktiengesellschaft is outperforming the sector as a whole this year.
Enhabit (EHAB) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 15.9%.
In Enhabit's case, the consensus EPS estimate for the current year increased 32.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Bayer Aktiengesellschaft belongs to the Large Cap Pharmaceuticals industry, which includes 12 individual stocks and currently sits at #69 in the Zacks Industry Rank. Stocks in this group have gained about 6.3% so far this year, so BAYRY is performing better this group in terms of year-to-date returns.
On the other hand, Enhabit belongs to the Medical Services industry. This 59-stock industry is currently ranked #77. The industry has moved +5.2% year to date.
Going forward, investors interested in Medical stocks should continue to pay close attention to Bayer Aktiengesellschaft and Enhabit as they could maintain their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report
Enhabit, Inc. (EHAB) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
July CPI Report Shows Firms Yet to Fully Pass Through Tariff Costs to Consumers, Experts Say
The latest consumer price index largely matched consensus expectations for July, showing that inflat Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
Should Value Investors Buy Array Technologies (ARRY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large. Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today. One company value investors might notice is Array Technologies (ARRY). ARRY is currently sporting a Zacks Rank #2 (Buy), as well as an A grade for Value. The stock has a Forward P/E ratio of 6.85. This compares to its industry's average Forward P/E of 13.33. ARRY's Forward P/E has been as high as 12.17 and as low as 5.23, with a median of 7.81, all within the past year. Investors will also notice that ARRY has a PEG ratio of 0.32. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ARRY's industry has an average PEG of 0.60 right now. Over the last 12 months, ARRY's PEG has been as high as 1.22 and as low as 0.28, with a median of 0.67. Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. This is a preferred metric because revenue can't really be manipulated, so sales are often a truer performance indicator. ARRY has a P/S ratio of 0.73. This compares to its industry's average P/S of 1.12. Finally, investors will want to recognize that ARRY has a P/CF ratio of 10.52. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 11.66. ARRY's P/CF has been as high as 21.25 and as low as 6.15, with a median of 11.64, all within the past year. These are only a few of the key metrics included in Array Technologies's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, ARRY looks like an impressive value stock at the moment. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Array Technologies, Inc. (ARRY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
14 hours ago
- Yahoo
Xometry, Inc. (XMTR) Soars to 52-Week High, Time to Cash Out?
Shares of Xometry (XMTR) have been strong performers lately, with the stock up 36.9% over the past month. The stock hit a new 52-week high of $48.6 in the previous session. Xometry has gained 11.3% since the start of the year compared to the 6.9% gain for the Zacks Industrial Products sector and the 7.2% return for the Zacks Manufacturing - General Industrial industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on August 5, 2025, Xometry reported EPS of $0.09 versus consensus estimate of $0.05. For the current fiscal year, Xometry is expected to post earnings of $0.35 per share on $657.33 in revenues. This represents a 975% change in EPS on a 20.49% change in revenues. For the next fiscal year, the company is expected to earn $0.82 per share on $778.59 in revenues. This represents a year-over-year change of 134.29% and 18.45%, respectively. Valuation Metrics While Xometry has moved to its 52-week high over the past few weeks, investors need to be asking, what is next for the company? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself. On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style. Xometry has a Value Score of F. The stock's Growth and Momentum Scores are A and A, respectively, giving the company a VGM Score of B. In terms of its value breakdown, the stock currently trades at 135.6X current fiscal year EPS estimates, which is a premium to the peer industry average of 23.3X. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective. Zacks Rank We also need to consider the stock's Zacks Rank, as this supersedes any trend on the style score front. Fortunately, Xometry currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts. Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Xometry fits the bill. Thus, it seems as though Xometry shares could still be poised for more gains ahead. How Does XMTR Stack Up to the Competition? Shares of XMTR have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is Gorman-Rupp Company (The) (GRC). GRC has a Zacks Rank of #2 (Buy) and a Value Score of C, a Growth Score of B, and a Momentum Score of C. Earnings were strong last quarter. Gorman-Rupp Company (The) beat our consensus estimate by 9.09%, and for the current fiscal year, GRC is expected to post earnings of $2.04 per share on revenue of $680.77 million. Shares of Gorman-Rupp Company (The) have gained 16.5% over the past month, and currently trade at a forward P/E of 20.93X and a P/CF of 13.94X. The Manufacturing - General Industrial industry is in the top 14% of all the industries we have in our universe, so it looks like there are some nice tailwinds for XMTR and GRC, even beyond their own solid fundamental situation. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Xometry, Inc. (XMTR) : Free Stock Analysis Report Gorman-Rupp Company (The) (GRC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
